EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Artificial Intelligence in Digital Pathology of Prostate Cancer: A Systematic Review of Clinical Validation and Pathologist Assistance

Ildar Fakhradiyev, Marat Shoranov, Yerlan Ismoldayev, Mirzakarim Alchinbayev, Shynar Tanabayeva, Anel Ibrayeva

Cancers · 14.11.2026 · 18 (22) · 3643

DOI: 10.3390/cancers18223643 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Cancers, online erschienen am 14.11.2026. Verfasst von Ildar Fakhradiyev und 5 weiteren Autor:innen. Die Arbeit nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: S.D. Asfendiyarov Kazakh National Medical University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Artificial intelligence (AI) may support prostate cancer diagnosis, but its clinical value depends on validation conditions. We synthesized evidence on its clinical validation in digital pathology and evaluated performance in cancer detection, grading, and pathologist assistance.

Methods

PubMed/MEDLINE, Scopus, Web of Science Core Collection, Embase, and IEEE Xplore were searched through 28 September 2026, inclusive. The clinical synthesis included studies of digitized hematoxylin and eosin-stained histological specimens reporting cancer detection, Gleason/ISUP grading, or pathologist-assistance outcomes at the biopsy, slide, case, or patient level. Studies limited to patches were assigned to the broader evidence map. Two reviewers independently selected studies; risk of bias was assessed using QUADAS-2. Data were synthesized descriptively, without meta-analysis.

Results

The broader evidence map included 562 publications; the clinical synthesis included 52 publications and 79 contributions: 34 on cancer detection, 31 on grading, and 14 on pathologist assistance or implementation. In one independent test involving 535 biopsies, the area under the ROC curve was 0.990 (95% CI 0.982–0.996). In another series, exact Grade Group agreement was recorded in 57 of 109 cancer specimens (52.3%), with a quadratic weighted kappa of 0.87. In one study, pathologists’ sensitivity increased from 88.7% to 96.6% with AI assistance. Overall risk of bias was high in 33 publications and unclear in 19.

Conclusions

The findings support further clinical evaluation of AI for cancer detection, grading, and second review. Implementation requires local validation of operating thresholds and assessment of diagnostic errors and workflow impact.

Förderung

  • S.D. Asfendiyarov Kazakh National Medical University

Zitieren

APA

Fakhradiyev, I., Shoranov, M., Ismoldayev, Y., Alchinbayev, M., Tanabayeva, S., & Ibrayeva, A. (2026). Artificial Intelligence in Digital Pathology of Prostate Cancer: A Systematic Review of Clinical Validation and Pathologist Assistance. Cancers, 18(22), 3643. https://doi.org/10.3390/cancers18223643

Vancouver

Fakhradiyev I, Shoranov M, Ismoldayev Y, Alchinbayev M, Tanabayeva S, Ibrayeva A. Artificial Intelligence in Digital Pathology of Prostate Cancer: A Systematic Review of Clinical Validation and Pathologist Assistance. Cancers. 2026;18(22):3643. doi:10.3390/cancers18223643

BibTeX
@article{Fakhradiyev2026,
  author = {Fakhradiyev, Ildar and Shoranov, Marat and Ismoldayev, Yerlan and Alchinbayev, Mirzakarim and Tanabayeva, Shynar and Ibrayeva, Anel},
  title = {Artificial Intelligence in Digital Pathology of Prostate Cancer: A Systematic Review of Clinical Validation and Pathologist Assistance},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {22},
  pages = {3643},
  doi = {10.3390/cancers18223643}
}
Kostenlos starten →